跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
NMPA
/
Cefuroxime Sodium for Injection
Approved
化学药品
Cefuroxime Sodium for Injection
ESSETI FARMACEUTICI SRL
🇨🇳 National Medical Products Administration
Approval Date
Nov 26, 2025
Approval ID
8880hdwlI2W
Company
ESSETI FARMACEUTICI SRL
Type
化学药品
Approval Details
Approval Id
8880hdwlI2W
Approval Number
国药准字HJ20160013
Generic Name
注射用头孢呋辛钠
Generic Name En
Cefuroxime Sodium for Injection
Trade Name
明可欣
Brand Name
明可欣
Drug Type
化学药品
Dosage Form
注射剂
Strength
1.5g(按C₁₆H₁₆N₄O₈S计)
Reg Date
2025-11-26
Expired Date
2030-11-25
Company Name
ESSETI FARMACEUTICI SRL
Production Company Name
ESSETI FARMACEUTICI SRL
Company Detail Path
/organization/esseti-farmaceutici-srl
Production Company Detail Path
/organization/esseti-farmaceutici-srl
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 26, 2025
Approval ID
8880hdwlI2W
Type
化学药品
Back to NMPA Approvals
明可欣 - NMPA Drug Approval Details